Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
What's Your Reaction?
Or register with email
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
Total Vote: 0
Send Message on kartavyasolution@gmail.com
